ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Why Teladoc (TDOC) Stock Is Up Today

TDOC Cover Image

What Happened?

Shares of digital medical services platform Teladoc Health (NYSE: TDOC) jumped 4.4% in the afternoon session after Deutsche Bank upgraded the stock to Buy from Hold. 

The bank set a price target of $11, noting the telehealth provider's low valuation and plans to reshape its BetterHelp unit as reasons for the improved outlook. According to the bank, these factors created a path for the shares to rise. The new rating and price target signaled strong confidence in the company's future prospects, which resonated positively with investors.

Is now the time to buy Teladoc? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Teladoc’s shares are extremely volatile and have had 36 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 12 days ago when the stock gained 13.5% on the news that the company reported fourth-quarter results that surpassed analyst expectations, along with a narrower loss, even as it provided a cautious outlook for the year ahead. The virtual healthcare company posted revenue of $642.3 million, which was slightly ahead of Wall Street's estimates. A key positive for investors was the improvement on the bottom line, with the quarterly loss per share narrowing to $0.14 from $0.28 in the same period of the previous year. This result also beat market forecasts. However, the company's guidance for the upcoming first quarter and the full year 2026 came in below what analysts had anticipated. Despite the soft forecast, the market's positive reaction suggested investors placed more weight on the strong quarterly performance and improved profitability.

Teladoc is down 20.9% since the beginning of the year, and at $5.58 per share, it is trading 41.1% below its 52-week high of $9.46 from October 2025. Investors who bought $1,000 worth of Teladoc’s shares 5 years ago would now be looking at an investment worth $30.22.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.87
-5.33 (-2.48%)
AAPL  249.94
-4.29 (-1.69%)
AMD  199.46
+3.15 (1.60%)
BAC  46.83
-0.45 (-0.95%)
GOOG  306.30
-3.11 (-1.01%)
META  615.68
-6.98 (-1.12%)
MSFT  391.67
-7.74 (-1.94%)
NVDA  180.40
-1.53 (-0.84%)
ORCL  152.90
-1.79 (-1.16%)
TSLA  392.78
-6.49 (-1.63%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.